Beijing Konruns Pharmaceutical Co., Ltd. Class ASSE: 603590

"Beijing Konruns Pharmaceutical Co., Ltd."Semi-annual Report for 2026

Aug 26, 2026 · Issued by Beijing Konruns Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Semi-annual Report for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Beijing Konruns Pharmaceutical Co., Ltd. Class A

"Beijing Konruns Pharmaceutical Co., Ltd."Self-inspection Report on Trading in the Company's Shares by Insiders with Access to Inside Information in Relation to the 2026 Restricted Share Incentive PlanAug 7
"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing SharesAug 5
"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Redemption of Cash Management Products Purchased with Certain Idle Raised FundsAug 1
"Beijing Konruns Pharmaceutical Co., Ltd."Review Opinion and Statement on the Public Disclosure of the List of Participants for the Initial Grant under the Company's 2026 Restricted Stock Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of DirectorsJul 15

All Beijing Konruns Pharmaceutical Co., Ltd. Class A news releases